COVID- 19 vaccination reduces new-onset fibromyalgia risk in survivors
Our findings suggest that COVID-19 vaccination may play a protective role in reducing the risk of new-onset FM among COVID-19 survivors. The findings may indicate the importance of targeting vaccination to specific subgroups, such as males, individuals with lower BMIs, and those with mental health conditions, including depression and anxiety. This approach may enhance the protective effects of the vaccine and further reduce the incidence of long-term health complications associated with COVID-19. Further research is needed to validate these observations.
Authors
- Pei‐Lun Liao (ORCID: https://orcid.org/0000-0002-6645-3657)
- Zhenhua Ying (ORCID: https://orcid.org/0000-0002-7175-8455)
- Aihui Liu (ORCID: https://orcid.org/0000-0002-1138-6055)
- James Cheng‐Chung Wei (ORCID: https://orcid.org/0000-0002-1235-0679)
- Hongyang Jiang (ORCID: https://orcid.org/0000-0001-8205-7059)
- Shan Huang (ORCID: https://orcid.org/0009-0002-0137-3979)
- Shinan Li
Institutions
- Zhejiang Provincial Hospital of TCM (CN)
- Chung Shan Medical University Hospital (TW)
- Hangzhou Medical College (CN)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1186/s12916-025-04069-z
- Citations
- 1
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- National Natural Science Foundation of China
- Tongji University
- China Medical University
- Shanxi Medical University
- Chung Shan Medical University
- Chung Shan Medical University Hospital